Company Financials

AstraZeneca Financials

Pound sterling

business AstraZeneca Company Profile

Main Stock Listing

LSE: AZN

Market Capitalization £211.30 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 30.41
Forward PE 17.56
Price to Sales TTM £3.63
Price to Book MRQ £618.63
Enterprise to Revenue 4.10
Enterprise to EBITDA 11.68

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 16.17%
Operating Margin 24.11%
Return on Assets TTM 9.06%
Return on Equity TTM 21.67%

Income Statement

Revenue TTM £43,247,068,936
Revenue per Share TTM £37.50
Quarterly Revenue Growth 12.00%
Gross Profit TTM £36,006,365,330
EBITDA £13,411,524,256
Net Income to Common TTM £6,992,950,037
Diluted EPS TTM £4.47
Quarterly Earnings Growth YoY 77.30%

Balance Sheet

Total Cash MRQ £6,087,489,915
Total Cash per Share MRQ £5.28
Total Debt MRQ £
Total Debt to Equity MRQ 71.05
Current Ratio MRQ 0.88
Book Value per Share MRQ £21.97

Cash Flow

Operating Cash Flow TTM £11,264,311,209
Levered Free Cash Flow TTM £7,425,498,833

AZN Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 1,550,259,603
Float Shares 1,543,307,040
Avg 10 Volume 2,734,195
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 0.03%
% Held by Institutions 55.60%

Stock Price Summary

Beta 0.17
Fifty Two Week Low £9573.51
Fifty Two Week High £15474.36
Fifty Two Week Change 21.19%
Day 50 MA £13397.80
Day 200 MA £11635.53

Dividends and Splits

Forward Annual Dividend Rate £153.40
Forward Annual Dividend Yield 1.13%
Trailing Annual Dividend Rate £244.70
Trailing Annual Dividend Yield 1.80%
Payout Ratio 52.05%
Dividend Date
Ex Dividend Date 2025-08-07
Last Split Factor
Last Split Date